 "covid, coronavirus, vaccine, drug, pharma, medicine, cure")
Hyderabad-based Dr Reddy's Laboratories (DRL) launched the innovator brand of favipiravir Avigan, an antiviral used to treat mild to moderate Covid-19 patients, in India. Priced at Rs 99 per tablet, the drug would be imported from Japan now.
DRL plans to manufacture the drug here in India soon. M V Ramana, CEO, Branded Markets (India and Emerging Markets), DRL said that the process of technology transfer is on with Fujifilm and DRL will be able to start manufacturing in India within a quarter or so. The company is also planning to ship it to patients who call its helpline directly
